BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shao H, Li B, Li H, Gao L, Zhang C, Sheng H, Zhu L. Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides. Molecules 2021;27:51. [PMID: 35011278 DOI: 10.3390/molecules27010051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Ye G, Huang W, Chen Z, Zhong H, Zhong J, Guo X, Huang Y, Kandalai S, Zhou X, Zhang N, Zhou Y, Zheng Q, Tian H. Tunable Toxicity of Bufadienolides is Regulated through a Configuration Inversion Catalyzed by a Short-Chain Dehydrogenase/Reductase. Chembiochem 2022;23:e202200473. [PMID: 36125775 DOI: 10.1002/cbic.202200473] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Liu Q, Sun H, Li X, Sheng H, Zhu L. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. Molecules 2022;27. [PMID: 36431851 DOI: 10.3390/molecules27227740] [Reference Citation Analysis]
3 Zou D, Wang Q, Chen T, Sang D, Yang T, Wang Y, Gao M, He F, Li Y, He L, Longzhu D. Bufadienolides originated from toad source and their anti-inflammatory activity. Front Pharmacol 2022;13:1044027. [DOI: 10.3389/fphar.2022.1044027] [Reference Citation Analysis]
4 Soumoy L, Ghanem GE, Saussez S, Journe F. Bufalin for an innovative therapeutic approach against cancer. Pharmacol Res 2022;184:106442. [PMID: 36096424 DOI: 10.1016/j.phrs.2022.106442] [Reference Citation Analysis]